Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,360 Cr₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹9,360 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,360 Cr
Mar2024₹7,845 Cr
Mar2023₹7,767 Cr
Mar2022₹8,960 Cr
Mar2021₹6,969 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹9,360 Cr
19.31
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹164,211.8 Cr -4.5% 0.7% 3.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,062.0 Cr 0.4% 2.6% NA Stock Analytics
TORRENT PHARMACEUTICALS ₹144,129.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,513.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,250.0 Cr 1.2% 10.2% 4.8% Stock Analytics
MANKIND PHARMA ₹85,198.8 Cr -1.1% -2.6% -15.1% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-4.5%

0.7%

3.4%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses